1 ML alirocumab 150 MG/ML Auto-Injector

RxCUI: 1659156
RxNorm name: 1 ML alirocumab 150 MG/ML Auto-Injector
Display name: 1 ML alirocumab 150 MG/ML Auto-Injector
Full name: 1 ML alirocumab 150 MG/ML Auto-Injector
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:56

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125559	Praluent	alirocumab	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Praluent	ALIROCUMAB	Regeneron Pharmaceuticals, Inc.	7bcfbac2-e8ac-4569-8edc-bcde3b1fd172	2026-07-16	Warnings, Adverse reactions	Exact identifier rxcui: 1659156
Praluent	ALIROCUMAB	Sanofi-Aventis U.S. LLC	446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4	2026-07-07	Warnings, Adverse reactions	Exact identifier rxcui: 1659156

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4	alirocumab 150 MG in 1 ML Auto-Injector	PSN	33	These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015	20251023
446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4	alirocumab 150 MG per 1 ML Auto-Injector	SY	33	These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015	20251023
446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4	1 ML alirocumab 150 MG/ML Auto-Injector	SCD	33	These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015	20251023
7bcfbac2-e8ac-4569-8edc-bcde3b1fd172	alirocumab 150 MG per 1 ML Auto-Injector	SY	9	These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015	20251030
7bcfbac2-e8ac-4569-8edc-bcde3b1fd172	1 ML alirocumab 150 MG/ML Auto-Injector	SCD	9	These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015	20251030
7bcfbac2-e8ac-4569-8edc-bcde3b1fd172	alirocumab 150 MG in 1 ML Auto-Injector	PSN	9	These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015	20251030